These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

66 related articles for article (PubMed ID: 20434711)

  • 1. Parotid gland function after radiotherapy.
    Raaijmakers CP; Roesink JM; Dijkema T; Houweling AC; Terhaard CH
    Lancet Oncol; 2010 May; 11(5):412. PubMed ID: 20434711
    [No Abstract]   [Full Text] [Related]  

  • 2. Parotid gland function after radiotherapy.
    Dirix P; Nuyts S
    Lancet Oncol; 2010 Jun; 11(6):515-6. PubMed ID: 20522382
    [No Abstract]   [Full Text] [Related]  

  • 3. Parotid-gland-sparing 3D conformal radiotherapy in patients with bilateral radiotherapy of the head and neck region--results in clinical practice.
    Hey J; Setz J; Gerlach R; Janich M; Sehlleier S; Schaller HG; Gernhardt CR; Kuhnt T
    Oral Oncol; 2009 Feb; 45(2):e11-7. PubMed ID: 18621572
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A comparison of dose-response models for the parotid gland in a large group of head-and-neck cancer patients.
    Houweling AC; Philippens ME; Dijkema T; Roesink JM; Terhaard CH; Schilstra C; Ten Haken RK; Eisbruch A; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2010 Mar; 76(4):1259-65. PubMed ID: 20005639
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Large cohort dose-volume response analysis of parotid gland function after radiotherapy: intensity-modulated versus conventional radiotherapy.
    Dijkema T; Terhaard CH; Roesink JM; Braam PM; van Gils CH; Moerland MA; Raaijmakers CP
    Int J Radiat Oncol Biol Phys; 2008 Nov; 72(4):1101-9. PubMed ID: 18472355
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Effect of radiotherapy on the function of the parotid gland].
    Simorić S; Sprem N; Voskresensky I; Racić G
    Laryngol Rhinol Otol (Stuttg); 1987 Sep; 66(9):503-6. PubMed ID: 3683045
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The function of the parotid gland following radiation therapy for head and neck cancer.
    Cheng VS; Downs J; Herbert D; Aramany M
    Int J Radiat Oncol Biol Phys; 1981 Feb; 7(2):253-8. PubMed ID: 7216860
    [No Abstract]   [Full Text] [Related]  

  • 8. Radiation injury of the parotid glands during treatment for head and neck cancer: assessment using dynamic contrast-enhanced MR imaging.
    Lee FK; King AD; Kam MK; Ma BB; Yeung DK
    Radiat Res; 2011 Mar; 175(3):291-6. PubMed ID: 21388272
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phenomenologic model describing flow reduction for parotid gland irradiation with intensity-modulated radiotherapy: evidence of significant recovery effect.
    Scrimger RA; Stavrev P; Parliament MB; Field C; Thompson H; Stavreva N; Fallone BG
    Int J Radiat Oncol Biol Phys; 2004 Sep; 60(1):178-85. PubMed ID: 15337554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Dose-volume modeling of salivary function in patients with head-and-neck cancer receiving radiotherapy.
    Blanco AI; Chao KS; El Naqa I; Franklin GE; Zakarian K; Vicic M; Deasy JO
    Int J Radiat Oncol Biol Phys; 2005 Jul; 62(4):1055-69. PubMed ID: 15990009
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Radiation-induced volume changes in parotid and submandibular glands in patients with head and neck cancer receiving postoperative radiotherapy: a longitudinal study.
    Wang ZH; Yan C; Zhang ZY; Zhang CP; Hu HS; Kirwan J; Mendenhall WM
    Laryngoscope; 2009 Oct; 119(10):1966-74. PubMed ID: 19688858
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Recurrences after conformal parotid-sparing radiotherapy for head and neck cancer.
    Bussels B; Maes A; Hermans R; Nuyts S; Weltens C; Van den Bogaert W
    Radiother Oncol; 2004 Aug; 72(2):119-27. PubMed ID: 15297131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Conformal and intensity modulated irradiation of head and neck cancer: the potential for improved target irradiation, salivary gland function, and quality of life.
    Eisbruch A; Dawson LA; Kim HM; Bradford CR; Terrell JE; Chepeha DB; Teknos TN; Anzai Y; Marsh LH; Martel MK; Ten Haken RK; Wolf GT; Ship JA
    Acta Otorhinolaryngol Belg; 1999; 53(3):271-5. PubMed ID: 10635407
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Parotid dosimetric changes correlate to weight loss during radical but not adjuvant head and neck radiotherapy: an exploratory analysis.
    Chatterjee S; Sarkar S; Mahata A; Roy R; Achari R; Mallick I
    Clin Oncol (R Coll Radiol); 2013 Nov; 25(11):685-6. PubMed ID: 23994039
    [No Abstract]   [Full Text] [Related]  

  • 15. A quantitative assessment of volumetric and anatomic changes of the parotid gland during intensity-modulated radiotherapy for head and neck cancer using serial computed tomography.
    Ajani AA; Qureshi MM; Kovalchuk N; Orlina L; Sakai O; Truong MT
    Med Dosim; 2013; 38(3):238-42. PubMed ID: 23558146
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Frequent short-term oral complications of head and neck radiotherapy.
    Mossman KL
    Ear Nose Throat J; 1994 May; 73(5):316-20. PubMed ID: 8045235
    [No Abstract]   [Full Text] [Related]  

  • 17. 3D-conformal-intensity modulated radiotherapy with compensators for head and neck cancer: clinical results of normal tissue sparing.
    Wendt TG; Abbasi-Senger N; Salz H; Pinquart I; Koscielny S; Przetak SM; Wiezorek T
    Radiat Oncol; 2006 Jun; 1():18. PubMed ID: 16790059
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Simultaneous integrated boost intensity-modulated radiotherapy for locally advanced head-and-neck squamous cell carcinomas: II--clinical results.
    Lauve A; Morris M; Schmidt-Ullrich R; Wu Q; Mohan R; Abayomi O; Buck D; Holdford D; Dawson K; Dinardo L; Reiter E
    Int J Radiat Oncol Biol Phys; 2004 Oct; 60(2):374-87. PubMed ID: 15380569
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase II study to assess the efficacy of amifostine for submandibular/sublingual salivary sparing during the treatment of head and neck cancer with intensity modulated radiation therapy for parotid salivary sparing.
    Rosenthal DI; Chambers MS; Weber RS; Eisbruch A
    Semin Oncol; 2004 Dec; 31(6 Suppl 18):25-8. PubMed ID: 15726519
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Preservation of oral health-related quality of life and salivary flow rates after inverse-planned intensity- modulated radiotherapy (IMRT) for head-and-neck cancer.
    Parliament MB; Scrimger RA; Anderson SG; Kurien EC; Thompson HK; Field GC; Hanson J
    Int J Radiat Oncol Biol Phys; 2004 Mar; 58(3):663-73. PubMed ID: 14967418
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.